Shaping better health
REMEDY : BNSSG referral pathways & Joint Formulary

BNSSG Paediatric Joint Formulary
Home > Formulary : Paediatric > Recent Decisions > 2021 >

Decisions 14th September 2021

At the meeting on the 14th September the following decisions were agreed

New Drug Requests

Approved

Ranibizumab (Lucentis) (TLS Red)

  • For the treatment of retinopathy of prematurity disease in preterm babies